Stock recap shared on X this week: $BURU +120% · $NCPL +30% · $BRAI +10% · $NEXR +25% · $SPRC +10%
DM my assistant to join the group:: https://t.co/Gnt3gnnreZ
The tape moves too fast, so I started this private WhatsApp group to stay in touch with everyone in real time. I’ll share detailed setups and the latest market notes every day — completely free!
Stock recap shared on X this week: $BURU +120% · $NCPL +30% · $BRAI +10% · $NEXR +25% · $SPRC +10%
DM my assistant to join the group:: https://t.co/Gnt3gnnreZ
The tape moves too fast, so I started this private WhatsApp group to stay in touch with everyone in real time. I’ll share detailed setups and the latest market notes every day — completely free!
$INO’s lead DNA immunotherapy Voceryq received accelerated approval for RRP. Trial data showed some patients went a full year without surgery. First commercial product for the company and the market clearly liked it
$BURU just got the official nod that it’s back in compliance with NYSE American listing standards. That overhang is gone, and the stock already showed it can move on the news. Defense platform story is still intact
Netcapital’s private capital platform is still running while the company works through its filings. $NCPL reclaiming compliance on the bid price takes a real weight off. Momentum traders are paying attention
Netcapital’s private capital platform is still running while the company works through its filings. $NCPL reclaiming compliance on the bid price takes a real weight off. Momentum traders are paying attention
$BURU just got the official nod that it’s back in compliance with NYSE American listing standards. That overhang is gone, and the stock already showed it can move on the news. Defense platform story is still intact
$BURU just got the official nod that it’s back in compliance with NYSE American listing standards. That overhang is gone, and the stock already showed it can move on the news. Defense platform story is still intact
Netcapital’s private capital platform is still running while the company works through its filings. $NCPL reclaiming compliance on the bid price takes a real weight off. Momentum traders are paying attention
RADIUS already handling millions of customer interactions, and now they’ve added Force AI on top. $BRAI is quietly turning a working platform into something more flexible. Market’s starting to notice
RADIUS already handling millions of customer interactions, and now they’ve added Force AI on top. $BRAI is quietly turning a working platform into something more flexible. Market’s starting to notice
KeepZone AI sale gives $NEXR real capital optionality. $1M at close plus a profit share that could reach $5M. Small company, but the math just got a little more interesting
KeepZone AI sale gives $NEXR real capital optionality. $1M at close plus a profit share that could reach $5M. Small company, but the math just got a little more interesting
Extremely low market cap and tight float on $SPRC. Clinical update on the Tourette study plus the strategic move into AI. Price ran from ~1.07 to 2.41 before cooling off — now consolidating. Worth watching for the next volume surge
Extremely low market cap and tight float on $SPRC. Clinical update on the Tourette study plus the strategic move into AI. Price ran from ~1.07 to 2.41 before cooling off — now consolidating. Worth watching for the next volume surge
$BKYI just added another Middle East government customer for its biometric IAM platform. Seventh new one in the region in six months. Fundamentals still thin, but the sales traction and high gross margins give it a clearer story than most micro-caps at this level.
$BKYI just added another Middle East government customer for its biometric IAM platform. Seventh new one in the region in six months. Fundamentals still thin, but the sales traction and high gross margins give it a clearer story than most micro-caps at this level.